LRA Welcomes Positive Results with Anifrolumab for Reducing Lupus Flares
May 13, 2021
A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced...
TULIP-1
Promising New Lupus Treatments Highlighted ACR Annual Meeting
Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting
June 3, 2020
The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...